Asthma Research Today is a free monthly online journal that collates and summarizes the latest research about Asthma, including details on symptoms, diagnosis, treatment, causes, medications.

Volume 2 (2005), Issue 1 (January)

1. Addition of formoterol or montelukast to low-dose budesonide: an efficacy comparison in short- and long-term asthma control.
   Respiration, 71(6): 594-601. [Abstract] [Full-text]
2. Direct medical cost of asthma in Ankara, Turkey.
   Respiration, 71(6): 587-93. [Abstract] [Full-text]
3. Potential role of c-Jun NH2-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125.
   Eur J Pharmacol, 506(3): 273-83. [Abstract] [Full-text]
4. Reduced expression of transforming growth factor beta 1 exacerbates pathology in an experimental asthma model.
   Eur J Immunol, 35(1): 198-206. [Abstract] [Full-text]
5. Mitogen-activated protein kinases and asthma.
   J Cell Physiol, 202(3): 642-53. [Abstract] [Full-text]
6. A1 antagonism in asthma: better than coffee?
   J Clin Invest, 115(1): 13-6. [Abstract] [Full-text]
7. Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness.
   J Exp Med, 201(1): 73-82. [Abstract] [Full-text]
8. Short-term impact of a randomized multifaceted intervention for wheezing infants in low-income families.
   Arch Pediatr Adolesc Med, 159(1): 75-82. [Abstract] [Full-text]
9. Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis.
   Pediatrics, 115(1): 129-34. [Abstract] [Full-text]
10. Mast cells and basophils: friends as well as foes in bronchial asthma?
    Trends Immunol, 26(1): 25-31. [Abstract] [Full-text]
11. Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction.
    Pediatr Pulmonol, 39(2): 162-6. [Abstract] [Full-text]
12. Correlation between inhalant allergen-specific IgE and pulmonary function in children with asthma.
    Pediatr Pulmonol, 39(2): 150-5. [Abstract] [Full-text]
13. Clinical efficacy of n-3 fatty acid supplementation in patients with asthma.
    J Am Diet Assoc, 105(1): 98-105. [Abstract] [Full-text]
14. Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21.
    Am J Hum Genet, 76(2): 349-57. [Abstract] [Full-text]
15. Association of an intragenic microsatellite marker in the CC16 gene with asthma in the Indian population.
    J Hum Genet, 49(12): 677-83. [Abstract] [Full-text]
16. The September epidemic of asthma exacerbations in children: a search for etiology.
    J Allergy Clin Immunol, 115(1): 132-8. [Abstract] [Full-text]
17. Increased TGF-beta2 in severe asthma with eosinophilia.
    J Allergy Clin Immunol, 115(1): 110-7. [Abstract] [Full-text]
18. Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways.
    J Allergy Clin Immunol, 115(1): 88-94. [Abstract] [Full-text]
19. Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes.
    J Allergy Clin Immunol, 115(1): 80-7. [Abstract] [Full-text]
20. Decreased prevalence of asthma among farm-reared children compared with those who are rural but not farm-reared.
    J Allergy Clin Immunol, 115(1): 67-73. [Abstract] [Full-text]
21. Adult asthma severity in individuals with a history of childhood asthma.
    J Allergy Clin Immunol, 115(1): 61-6. [Abstract] [Full-text]
22. Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound.
    J Allergy Clin Immunol, 115(1): 55-60. [Abstract] [Full-text]
23. The national montelukast survey.
    J Allergy Clin Immunol, 115(1): 47-54. [Abstract] [Full-text]
24. Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology.
    Eur Respir J, 25(1): 186-99. [Abstract] [Full-text]
25. Airway responsiveness to hypertonic saline: dose-response slope or PD15?
    Eur Respir J, 25(1): 153-8. [Abstract] [Full-text]
26. Asthma: prevalence and cost of illness.
    Eur Respir J, 25(1): 47-53. [Abstract] [Full-text]
27. Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma.
    Eur Respir J, 25(1): 41-6. [Abstract] [Full-text]
28. The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma.
    Clin Ther, 26(11): 1895-904. [Abstract] [Full-text]
29. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease.
    Lancet, 365(9454): 167-75. [Abstract] [Full-text]
30. An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children.
    Lancet, 365(9454): 142-9. [Abstract] [Full-text]
31. Antioxidant intake in pregnancy in relation to wheeze and eczema in the first two years of life.
    Am J Respir Crit Care Med, 171(2): 121-8. [Abstract] [Full-text]
32. Country of birth as a risk factor for asthma among Mexican Americans.
    Am J Respir Crit Care Med, 171(2): 103-8. [Abstract] [Full-text]
33. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.
    Am J Respir Crit Care Med, 171(2): 137-41. [Abstract] [Full-text]
34. Brain-derived neurotrophic factor in platelets and airflow limitation in asthma.
    Am J Respir Crit Care Med, 171(2): 115-20. [Abstract] [Full-text]
35. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma.
    Am J Respir Crit Care Med, 171(2): 129-36. [Abstract] [Full-text]
36. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking.
    Am J Respir Crit Care Med, 171(2): 109-14. [Abstract] [Full-text]
37. Health planning that magnifies the community's voice: allies against asthma.
    Health Educ Behav, 32(1): 113-28. [Abstract] [Full-text]
38. A home visiting asthma education program: challenges to program implementation.
    Health Educ Behav, 32(1): 42-56. [Abstract] [Full-text]
39. Effect of asthma intervention on children with undiagnosed asthma.
    J Pediatr, 146(1): 96-104. [Abstract] [Full-text]
40. Safety of budesonide inhalation suspension in infants aged six to twelve months with mild to moderate persistent asthma or recurrent wheeze.
    J Pediatr, 146(1): 91-5. [Abstract] [Full-text]
41. Effect of budesonide and montelukast in asthmatic children exposed to relevant allergens.
    Allergy, 60(2): 206-10. [Abstract] [Full-text]
42. Exposure to pets, and the association with hay fever, asthma, and atopic sensitization in rural children.
    Allergy, 60(2): 177-84. [Abstract] [Full-text]
43. Allergic rhinitis and asthma comorbidity in a survey of young adults in Italy.
    Allergy, 60(2): 165-70. [Abstract] [Full-text]
44. Nitric oxide and redox signaling in allergic airway inflammation.
    Antioxid Redox Signal, 7(1): 129-43. [Abstract] [Full-text]
45. The effect of formoterol over 24 h in patients with asthma: the role of enantiomers.
    Pulm Pharmacol Ther, 18(2): 109-13. [Abstract] [Full-text]
46. Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthma.
    Pulm Pharmacol Ther, 18(2): 89-92. [Abstract] [Full-text]
47. Introduction of standardised emergency department paediatric asthma clinical guidelines into a general metropolitan hospital.
    Accid Emerg Nurs, 13(1): 2-8. [Abstract] [Full-text]
48. Trichostatin A attenuates airway inflammation in mouse asthma model.
    Clin Exp Allergy, 35(1): 89-96. [Abstract] [Full-text]
49. Mucosal symptoms elicited by fragrance products in a population-based sample in relation to atopy and bronchial hyper-reactivity.
    Clin Exp Allergy, 35(1): 75-81. [Abstract] [Full-text]
50. Allergic diseases and asthma in relation to serum immunoglobulins and salivary immunoglobulin A in pre-school children: a follow-up community-based study.
    Clin Exp Allergy, 35(1): 64-9. [Abstract] [Full-text]
51. Serum concentrations of interferon-gamma and intercellular adhesion molecule-1 eight years after an early respiratory syncytial virus infection.
    Clin Exp Allergy, 35(1): 59-63. [Abstract] [Full-text]
52. Chemokine-receptor expression on T cells in lung compartments of challenged asthmatic patients.
    Clin Exp Allergy, 35(1): 26-33. [Abstract] [Full-text]
53. Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood.
    Clin Exp Allergy, 35(1): 18-25. [Abstract] [Full-text]
54. Atopy, asthma, and experimental approaches based on the linear model of T cell maturation.
    Clin Exp Allergy, 35(1): 8-17. [Abstract] [Full-text]
55. Bronchodilator treatment and deaths from asthma: case-control study.
    BMJ, 330(7483): 117. [Abstract] [Full-text]
56. Allergic rhinitis, asthma, and atopy among grape farmers in a rural population in Crete, Greece.
    Chest, 127(1): 372-8. [Abstract] [Full-text]
57. Deep inspiration avoidance and methacholine response in normal subjects and patients with asthma.
    Chest, 127(1): 135-42. [Abstract] [Full-text]
58. Effect of spirometric maneuver, nasal clip, and submaximal inspiratory effort on measurement of exhaled nitric oxide levels in asthmatic patients.
    Chest, 127(1): 131-4. [Abstract] [Full-text]
59. Phenol-containing saline solution as a diluent for adenosine 5'-monophosphate in bronchial challenge testing.
    Chest, 127(1): 125-30. [Abstract] [Full-text]
60. Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma.
    Chest, 127(1): 117-24. [Abstract] [Full-text]
61. The risk of nonvertebral fracture related to inhaled corticosteroid exposure among adults with chronic respiratory disease.
    Chest, 127(1): 89-97. [Abstract] [Full-text]
62. Airway remodeling in asthma: therapeutic implications of mechanisms.
    Physiology (Bethesda), 20: 28-35. [Abstract] [Full-text]
63. Asthma, the ugly duckling of lung disease proteomics?
    J Chromatogr B Analyt Technol Biomed Life Sci, 815(1): 285-94. [Abstract] [Full-text]
64. Efficacy of a traditional Korean medicine, Chung-Sang-Bo-Ha-Tang, in a murine model of chronic asthma.
    Int Immunopharmacol, 5(2): 427-36. [Abstract] [Full-text]
65. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
    J Pharmacol Exp Ther, 312(2): 432-40. [Abstract] [Full-text]
66. A new mouse model of lung allergy induced by the spores of Alternaria alternata and Cladosporium herbarum molds.
    Clin Exp Immunol, 139(2): 179-88. [Abstract] [Full-text]
67. Effects of bemiparin on airway responses to antigen in sensitized Brown-Norway rats.
    Eur J Pharmacol, 507(1): 261-71. [Abstract] [Full-text]
68. Profile of a primary care practice asthma program: improved patient outcomes in a high-risk population.
    J Pediatr Health Care, 19(1): 25-32. [Abstract] [Full-text]
69. Secretory products from infective forms of Nippostrongylus brasiliensis induce a rapid allergic airway inflammatory response.
    Immunol Cell Biol, 83(1): 40-7. [Abstract] [Full-text]
70. How appropriate is asthma therapy in general practice?
    Fundam Clin Pharmacol, 19(1): 107-15. [Abstract] [Full-text]
71. Gene-environment interactions in asthma and other respiratory diseases.
    Annu Rev Med, 56: 383-400. [Abstract] [Full-text]
72. The discovery of a selective, high affinity A(2B) adenosine receptor antagonist for the potential treatment of asthma.
    Bioorg Med Chem Lett, 15(3): 609-12. [Abstract] [Full-text]
73. Ethnic variations in UK asthma frequency, morbidity, and health-service use: a systematic review and meta-analysis.
    Lancet, 365(9456): 312-7. [Abstract] [Full-text]
74. Application of a propensity score approach for risk adjustment in profiling multiple physician groups on asthma care.
    Health Serv Res, 40(1): 253-78. [Abstract] [Full-text]
75. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients.
    Clin Exp Allergy, 34(12): 1899-904. [Abstract] [Full-text]
76. The effectiveness of intranasal corticosteroids in combined allergic rhinitis and asthma syndrome.
    Clin Exp Allergy, 34(12): 1883-9. [Abstract] [Full-text]
77. Mothers of very low birth weight infants have less atopy than mothers of full-term infants.
    Clin Exp Allergy, 34(12): 1851-4. [Abstract] [Full-text]
78. Single nucleotide polymorphism screening and association analysis--exclusion of integrin beta 7 and vitamin D receptor (chromosome 12q) as candidate genes for asthma.
    Clin Exp Allergy, 34(12): 1841-50. [Abstract] [Full-text]
79. Surfactant protein D deficiency influences allergic immune responses.
    Clin Exp Allergy, 34(12): 1819-26. [Abstract] [Full-text]
80. Development of a questionnaire weighted scoring system to target diagnostic examinations for asthma in adults: a modelling study.
    BMC Fam Pract, 5(1): 30. [Abstract] [Full-text]
81. Development of the multi-attribute Pediatric Asthma Health Outcome Measure (PAHOM).
    Int J Qual Health Care, 17(1): 23-30. [Abstract] [Full-text]
82. Uteroglobin-related protein 1(UGRP1) gene polymorphisms and atopic asthma in the Indian population.
    Int Arch Allergy Immunol, 136(1): 1-6. [Abstract] [Full-text]
83. Hyperventilation with cold versus dry air in 2- to 5-year-old children with asthma.
    Am J Respir Crit Care Med, 171(3): 238-41. [Abstract] [Full-text]
84. Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma.
    Am J Respir Crit Care Med, 171(3): 224-30. [Abstract] [Full-text]
85. Addressing the childhood asthma crisis in Harlem: the Harlem Children's Zone Asthma Initiative.
    Am J Public Health, 95(2): 245-9. [Abstract] [Full-text]
86. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
87. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
88. Inhaled beclomethasone versus placebo for chronic asthma.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
89. Rubbing ointments and asthma morbidity in adolescents.
    J Altern Complement Med, 10(6): 1097-9. [Abstract] [Full-text]
90. Omega-3 Fatty acids and airway hyperresponsiveness in asthma.
    J Altern Complement Med, 10(6): 1067-75. [Abstract] [Full-text]
91. Is risk-adjustor selection more important than statistical approach for provider profiling? Asthma as an example.
    Med Decis Making, 25(1): 20-34. [Abstract] [Full-text]
92. Preferential transmission and association of the -403 G --> A promoter RANTES polymorphism with atopic asthma.
    Genes Immun, 6(1): 24-30. [Abstract] [Full-text]
93. A comparison of plethysmography, spirometry and oscillometry for assessing the pulmonary effects of inhaled ipratropium bromide in healthy subjects and patients with asthma.
    Br J Clin Pharmacol, 59(2): 152-9. [Abstract] [Full-text]
94. Decreased nasal tolerance to allergic asthma in mice fed an amino acid-based protein-free diet.
    Ann N Y Acad Sci, 1029: 361-5. [Abstract] [Full-text]
95. The need for standardisation of peak flow charts.
    Thorax, 60(2): 164-7. [Abstract] [Full-text]
96. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
    Thorax, 60(2): 100-5. [Abstract] [Full-text]
97. Trends in the prevalence of respiratory symptoms and treatment in Dutch children over a 12 year period: results of the fourth consecutive survey.
    Thorax, 60(2): 97-9. [Abstract] [Full-text]
98. Ole e 2 and Ole e 10: new clinical aspects and genetic restrictions in olive pollen allergy.
    Allergy, 60(3): 360-5. [Abstract] [Full-text]
99. Association between allergic rhinitis and hospital resource use among asthmatic children in Norway.
    Allergy, 60(3): 338-42. [Abstract] [Full-text]
100. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
     Allergy, 60(3): 330-7. [Abstract] [Full-text]
101. Biochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmatics.
     Allergy, 60(3): 323-9. [Abstract] [Full-text]
102. Effect of inhaled corticosteroid on an immunoreactive thymus and activation-regulated chemokine expression in the bronchial biopsies from asthmatics.
     Allergy, 60(3): 317-22. [Abstract] [Full-text]
103. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
     Allergy, 60(3): 309-16. [Abstract] [Full-text]
104. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma.
     Allergy, 60(3): 302-8. [Abstract] [Full-text]
105. Signs of reversing trends in prevalence of asthma.
     Allergy, 60(3): 283-92. [Abstract] [Full-text]
106. Timing and nature of wheezing at the endpoint of a bronchial challenge in preschool children.
     Pediatr Pulmonol, 39(3): 262-7. [Abstract] [Full-text]
107. Predictors of disease severity in children with asthma in Hartford, Connecticut.
     Pediatr Pulmonol, 39(3): 268-75. [Abstract] [Full-text]

© 2004-2008 Asthma Research Today. All Rights Reserved.